Enalare Therapeutics Nominated for Two Citeline Awards in Recognition of Outstanding Clinical Efforts
Enalare Therapeutics Inc., a clinical stage biopharmaceutical company dedicated to developing novel compounds for the treatment of life-threatening critical care diseases and community health emergencies, announced today that it has been nominated for two prestigious Citeline Awards sponsored by Informa Pharma Intelligence in recognition of outstanding achievements in clinical research. Enalare is a finalist for the … Read more